[{"address1": "3580 CARMEL MOUNTAIN ROAD", "address2": "SUITE 200", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 727 1040", "fax": "858 614 7007", "website": "https://www.connectbiopharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is headquartered in San Diego, California.", "fullTimeEmployees": 62, "companyOfficers": [{"maxAge": 1, "name": "Dr. Barry D. Quart Pharm.D.", "age": 67, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 547466, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David L. Szekeres J.D.", "age": 50, "title": "President", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 409305, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Peraza CPA", "age": 47, "title": "Vice President of Finance", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 210889, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Cohn J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sean T. Ristine", "age": 54, "title": "Vice President of Human Resources", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lei  Sun Ph.D.", "age": 60, "title": "VP of Biologics & Head of CMC", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul  Collazo Ph.D.", "age": 57, "title": "VP & Global Head of Medical Affairs", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Srikanth  Pendyala M.D.", "title": "Senior Vice President of Clinical Development(Consultant)", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kimberly J. Manhard", "age": 64, "title": "Executive VP & Chief Development Officer", "yearBorn": 1960, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8, "open": 0.81, "dayLow": 0.7818, "dayHigh": 0.84, "regularMarketPreviousClose": 0.8, "regularMarketOpen": 0.81, "regularMarketDayLow": 0.7818, "regularMarketDayHigh": 0.84, "payoutRatio": 0.0, "forwardPE": -4.2, "volume": 57442, "regularMarketVolume": 57442, "averageVolume": 121222, "averageVolume10days": 71080, "averageDailyVolume10Day": 71080, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 46671324, "fiftyTwoWeekLow": 0.51, "fiftyTwoWeekHigh": 2.07, "priceToSalesTrailing12Months": 1.7927755, "fiftyDayAverage": 0.74702, "twoHundredDayAverage": 1.008335, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -36383712, "profitMargins": -0.66097, "floatShares": 14215852, "sharesOutstanding": 55561100, "sharesShort": 75924, "sharesShortPriorMonth": 64978, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.0014, "heldPercentInsiders": 0.40652, "heldPercentInstitutions": 0.43971002, "shortRatio": 0.38, "shortPercentOfFloat": 0.0022, "impliedSharesOutstanding": 55561100, "bookValue": 1.498, "priceToBook": 0.5607476, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -17207000, "trailingEps": -0.31, "forwardEps": -0.2, "enterpriseToRevenue": -1.398, "enterpriseToEbitda": 1.766, "52WeekChange": -0.504717, "SandP52WeekChange": 0.1189177, "quoteType": "EQUITY", "currentPrice": 0.84, "targetHighPrice": 8.0, "targetLowPrice": 6.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 83995000, "totalCashPerShare": 1.512, "ebitda": -20597000, "totalDebt": 940000, "quickRatio": 9.808, "currentRatio": 10.246, "totalRevenue": 26033000, "debtToEquity": 1.134, "revenuePerShare": 0.471, "returnOnAssets": -0.12465, "returnOnEquity": -0.17796, "grossProfits": 26033000, "freeCashflow": -5981250, "operatingCashflow": -32980000, "grossMargins": 1.0, "ebitdaMargins": -0.79119, "operatingMargins": -0.81689, "financialCurrency": "USD", "symbol": "CNTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NGM", "messageBoardId": "finmb_706016439", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 5.0, "regularMarketPrice": 0.84, "marketState": "CLOSED", "shortName": "Connect Biopharma Holdings Limi", "longName": "Connect Biopharma Holdings Limited", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1748636422, "regularMarketTime": 1748635202, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616160600000, "postMarketChangePercent": -3.52381, "postMarketPrice": 0.8104, "postMarketChange": -0.0296, "regularMarketChange": 0.04, "regularMarketDayRange": "0.7818 - 0.84", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 121222, "fiftyTwoWeekLowChange": 0.32999998, "fiftyTwoWeekLowChangePercent": 0.6470588, "fiftyTwoWeekRange": "0.51 - 2.07", "fiftyTwoWeekHighChange": -1.23, "fiftyTwoWeekHighChangePercent": -0.59420294, "fiftyTwoWeekChangePercent": -50.4717, "earningsTimestamp": 1747314002, "earningsTimestampStart": 1747314002, "earningsTimestampEnd": 1747314002, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.31, "epsForward": -0.2, "epsCurrentYear": -0.975, "priceEpsCurrentYear": -0.8615384, "fiftyDayAverageChange": 0.09297997, "fiftyDayAverageChangePercent": 0.12446784, "twoHundredDayAverageChange": -0.16833502, "twoHundredDayAverageChangePercent": -0.16694355, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "displayName": "Connect Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-05-31"}]